Mangrove Partners IM, LLC 13D and 13G filings for Cartesian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 12:38 pm Sale |
2023-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
Mangrove Partners IM, LLC | 137,575 2.590% |
-175,347 (-56.04%) |
Filing |
| 2023-02-14 1:45 pm Purchase |
2022-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
Mangrove Partners IM, LLC | 312,923 5.970% |
33,726 (+12.08%) |
Filing |
| 2022-07-27 4:37 pm Purchase |
2022-05-13 | 13G | Cartesian Therapeutics, Inc. RNAC |
Mangrove Partners IM, LLC | 279,197 5.370% |
12,500 (+4.69%) |
Filing |
| 2022-05-23 5:39 pm Purchase |
2022-05-13 | 13G | Cartesian Therapeutics, Inc. RNAC |
Mangrove Partners IM, LLC | 266,697 5.140% |
3,971 (+1.51%) |
Filing |